Giulia Leanza
Biografia
Date of birth: 11/05/1983
Place of birth: Rome, Italy
Citizenship: italian
Address and Telephone Numbers:
Office: Campus Bio-Medico University of Rome,
Department of Medicine
Unit of Endocrinology & Diabetes
Via Alvaro del Portillo 21,
00128, Roma. ITALY
Phone: +39 06225419151
E-mail: [email protected]
Curriculum
PRESENT POSITION
- September 2020- ongoing: Instructor of Biology for Fundamental of Basic Science 2, Medicine and Surgery, Campus Bio-Medico University of Rome;
- September 2022: Biology Coordinator for Fundamental of Basic Science 1 and Fundamental of Basic Science 2, Medicine and Surgery, Campus Bio-Medico University of Rome;
- September 2019- ongoing: Postdoctoral Research Fellow at Unit of Endocrinology and Diabetes, Department of Medicine, Campus Bio-Medico University of Rome;
- September 2019- ongoing: Discipline tutor of Biology for Fundamental of Basic Science 1 and Clinical Medicine 2, Medicine and Surgery, Campus Bio-Medico University of Rome
PREVIOUS ACADEMIC/PROFESSIONAL EXPERIENCES
- January 2017-July 2018: Fellow at Laboratory of Division of Bone and Mineral Diseases, Muskoskeletal Research Center, Department of Medicine, Washington University in St Louis (MO), USA;
- October 2014-December2014: Visiting Reasearch at Queen Mary University, William Harvey Institute, Biochemical Pharmacology, London, UK
EDUCATION
- July 2018: PhD, Integrated Biomedical Sciences and Bioethic, Endocrinology and Diabetes Department, Faculty of Medicine, “Università Campus Bio-Medico di Roma”, Rome, Italy;
- July 2014: Licensed Biology Doctor
- March 2014: Master of Science in Human Nutrition at University Campus Bio-Medico of Rome, Rome, Italy
- October 2011: Bachelor's degree in Molecular and Cellular Biology at Tor Vergata University of Rome, Rome – Italy
HONORS AND AWARDS
- 2021: ASBMR 2021 Annual Meeting “American Society for Bone and Mineral Research”- Young Investigation Award
- 2019: Centro Internazionale Studi Diabete (CISD), grant for the study “Bone fragility and type 1 diabetes. Study of risk factors for fragility fractures”.
- 2017/2018: SID- “Società Italiana di Diabetologia” 2 year international Fellowship for the project:” Pathophysiological Mechanisms Of Bone Fragility In Type 1 Diabetes”
- 2015: 15th SIOMMMS National Congress -Best abstract and oral presentation: “Risk Factors for fragility fractures in Type 1 Diabetes”
EDITORIAL RESPONSIBILITIES
- October 2022: Editorial Board of Diabetes/Metabolism Research and Reviews
- 2018-current: Reviewer, Journal of Clinical Endocrinology and Metabolism, Endocrine, Diabetes Obesity and Metabolism, Diabetes/Metabolism Research and Reviews
PUBBLICAZIONI
- Leanza, G., Conte, C., Cannata, F., et al. (2023). Oxidative Stress in Postmenopausal Women with or without Obesity. Cells, 12(8), 1137. https://doi.org/10.3390/cells12081137
- Maddaloni, E., Coraggio, L., Amendolara, R., et al. SUMMER Study in Diabetes Group (2023). Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes. Diabetes/metabolism research and reviews, e3632.
- Alhamar, G., Briganti, S., Maggi, D., et al. (2023). Pre-vaccination glucose time in range correlates with antibody response to SARS-CoV-2 vaccine in type 1 diabetes. The Journal of clinical endocrinology and metabolism, dgad001.
- Pantano, F., Tramontana, F., Iuliani, M., Leanza, G., et al. (2022). Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis. Journal of bone oncology, 37, 100459.
- Battisti, S., Napoli, N., Pedone, C., Lombardi, M., Leanza, G., et al. (2021). Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency. Endocrine, 2021,74(3), 461–469.
- Viola V, Tramontana F, Leanza G. Letter to the Editor from Viola et al.: "Diminishing Value from Multiple Serial Bone Densitometry in Women Receiving Antiresorptive Medication for Osteoporosis". J Clin Endocrinol Metab. 2022;107(1):e438-e439.
- Viola V, Leanza G, Tramontana F. Letter to the Editor From Viola et al: "Calcifediol Treatment and COVID-19-related Outcomes". J Clin Endocrinol Metab. 2021;106(12):e5271-e5272.
- Leanza, G., Fontana, F., Lee, et al. (2021). Gain-of-Function Lrp5 Mutation Improves Bone Mass and Strength and Delays Hyperglycemia in a Mouse Model of Insulin-Deficient Diabetes. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 36(7), 1403–1415.
- Fontana F, Xiang J, Su X, Tycksen E, et al. N-cadherin in osteolineage cells modulates stromal support of tumor growth. J Bone Oncol. 2021 Mar 23;28:100356.
- Piccoli A, Cannata F, Strollo R, Pedone C, Leanza G, et al. Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes. J Bone Miner Res. 2020 Dec;35(12):2415-2422. doi: 10.1002/jbmr.4153.
- Leanza G, Maddaloni E, Schwartz A, Napoli N. Response to: Letter to editor in response to article published by Leanza et al. Bone. 2019 Oct;127:675.
- Leanza G, Maddaloni E, Pitocco D, et al. “Risk factors for fragility fractures in type 1 diabetes”. Bone. 2019 Aug;125:194-199.
- Bertoccini L, Bailetti D; SUMMER Study in Diabetes Group, et al. Variability in genes regulating vitamin D metabolism is associated with vitamin D levels in type 2 diabetes. Oncotarget. 2018;9(79):34911-34918. Published 2018 Oct 9. doi:10.18632/oncotarget.26178
